✦ LIBER ✦

The CD34+90+ cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34+ cell dose

✍ Scribed by Chaudhry, A; Brown, C; Russell, J A; Gluck, S; Stewart, D A; Guo, D; Luider, J; Auer, I; Klassen, J; Morris, D

Book ID: 110012406
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 73 KB
Volume: 25
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702171

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors predicting engraftment of autolo

Factors predicting engraftment of autologous blood stem cells: CD34+ subsets inferior to the total CD34+ cell dose

✍ Stewart, D A; Guo, D; Luider, J; Auer, I; Klassen, J; Ching, E; Morris, D; Chaud 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

Viable CD34+/CD133+ blood progenitor cel

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

✍ C. Hicks; R. Wong; A. Manoharan; Y. L. Kwan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 221 KB

Failure to achieve a threshold dose of C

Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation

✍ Sartor, M M; Garvin, F; Antonenas, V; Bradstock, K F; Gottlieb, D J 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 245 KB

The number of CD34+ cells in peripheral

The number of CD34+ cells in peripheral blood as a predictor of the CD34+ yield in patients going to autologous stem cell transplantation

✍ A.L. Basquiera; P. Abichain; J.C. Damonte; B. Ricchi; A.G. Sturich; E.D. Palazzo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

The number of CD34+ cells in peripheral blood (PB) is a guide to the optimal timing to harvest peripheral blood progenitor cells (PBPC). The objective was to determine the number of CD34+ cells in PB that allows achieving a final apheresis product containing 1.5 • 10 6 CD34+ cells/kg, performing up

High-dose therapy in patients with Hodgk

High-dose therapy in patients with Hodgkin’s disease: the use of selected CD34+ cells is as safe as unmanipulated peripheral blood progenitor cells

✍ Blystad, A K; Holte, H; Kvaløy, S; Smeland, E; Delabie, J; Kvalheim, G 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 144 KB

The use of CD34+ mobilized peripheral bl

The use of CD34+ mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non-human primates

✍ Laurence E. Shields; Lakshmi Gaur; Patrick Delio; Mike Gough; Jennifer Potter; A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB